Gujarat: After Ram Navami violence, demolition drive begins in riot-hit Himmatnagar
Himmatnagar (PTI): Civic authorities have started a demolition drive against illegal structures in Gujarat's Himmatnagar city, where a communal clash had broken out during the Ram Navami celebration earlier this month, officials said on Tuesday.
Bulldozers were being used to remove encroachments in Chhapariya locality of Himmatnagar city in Sabarkantha district, they said.
"The municipality has started carrying out demolition in Chhapariya locality, which is close to where the communal clash had erupted on Ram Navami. Adequate security has been deployed in the area," Superintendent of Police Vishal Vaghela said.
A communal clash had broken out near Chhapariya area during a Ram Navami procession on April 10, when members from two communities resorted to pelting stones, leaving some people injured. Some vehicles were also set on fire during the clash.
The Anand district administration had also earlier carried out a demolition drive using bulldozers to remove structures owned by people allegedly involved in communal clashes in Khambhat town there during the Ram Navami celebration.
On April 10, a Ram Navami procession was also allegedly pelted with stones in Khambhat town. One person was killed and several others were injured in the ensuing violence.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Ballari maternal deaths: Karnataka govt. seeks explanation from CDSCO
Bengaluru: The Karnataka Government has sought clarification from the Central drugs standard control organisation following reports linking the serial deaths of pregnant women at Ballari District Hospital to unsafe IV Ringer's Lactate solution. Health Department Principal Secretary Harsha Gupta has written a letter to the Drugs Controller General of India, Rajeev Singh Raghuvanshi.
Recent Investigations revealed bacterial and fungal contaminants in the IV solution given to the women. Out of 192 batches supplied by a West Bengal-based pharmaceutical company, 22 were found substandard by the state drug control department, leading to the suspension of the medicine's use.
However, these batches had passed quality tests at the Central Drug Lab, creating a regulatory conflict.
The Health Department emphasized adherence to tender rules, stating that the Central Drug Lab's approval is legally binding. Samples from the problematic batches have been sent for re-testing at the central lab in West Bengal, with results expected on December 9.
As a precautionary measure, the state has blacklisted the implicated batches and issued directives to halt their use in all hospitals.
